CONFAB
Confab Laboratories Inc. is a privately held Canadian pharmaceutical CDMO that develops, manufactures, and packages non-sterile liquid, solid, and semi-solid dosage forms for prescription, OTC, generic, controlled, and veterinary pharmaceutical clients worldwide from its Saint-Hubert, Quebec facility.
- Company typePrivate
- Founded1983
- HeadquartersSaint-hubert, Canada
- Headcount101–250
- GTM typeB2B
- OfferingServices
What CONFAB does
Confab Laboratories Inc. is a privately held Canadian pharmaceutical Contract Development and Manufacturing Organization (CDMO) headquartered in a 100,200-square-foot facility in Saint-Hubert, Quebec. Founded in 1983 with roots tracing back more than four decades, the company specializes in non-sterile dosage forms — liquid, solid, and semi-solid — for prescription, over-the-counter, generic, controlled-substance, and veterinary pharmaceutical products. The integrated platform comprises 32 manufacturing suites and 17 packaging suites, an internal analytical laboratory with stability chambers, a 40,290-square-foot primary warehouse, an on-site mechanical workshop, and a Level 10 narcotic vault, all operating under FDA, Health Canada, EMEA mutual recognition, CFIA, Cofepris (Mexico), and PMDA (Japan) approvals.
Beyond manufacturing, Confab offers adjacent services including drug development (formulation and reverse engineering), technology transfer (engineering, regulatory, and validation batches), and pharmaceutical analysis (method development, verification, validation, transfer, and stability testing). Packaging capabilities include serialization and aggregation systems exceeding current mandatory traceability requirements, with vision systems for label compliance. The company serves enterprise pharmaceutical clients through a direct B2B sales motion — quote-based pricing driven by product type, packaging needs, target markets, and volume — with a dedicated project manager model providing continuity from development through commercialization. Global distribution of client products spans Canada, the United States, EMEA, Mexico, and Japan, supported from the single Quebec manufacturing site without disclosed offshore physical operations.
The business model is contract-based manufacturing revenue with multi-year client engagements and quote-driven, project-specific pricing rather than disclosed list pricing or subscription arrangements. Confab markets through its corporate website quote request system and standard professional social channels (LinkedIn, Facebook, YouTube, Instagram), targeting pharmaceutical companies seeking a single-source CDMO partner to reduce vendor management complexity across multiple dosage forms and regulatory jurisdictions. The company is independently owned with no disclosed private equity, venture capital, or parent-company control.
CONFAB firmographics
Firmographics- Name
- CONFAB
- Legal name
- Confab Laboratories Inc.
- Website
- https://confab.com
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Confab Laboratories Inc. is a privately held Canadian pharmaceutical CDMO that develops, manufactures, and packages non-sterile liquid, solid, and semi-solid dosage forms for prescription, OTC, generic, controlled, and veterinary pharmaceutical clients worldwide from its Saint-Hubert, Quebec facility.
- Ownership category
- akta.pro rank
CONFAB industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Packaging and Labeling Services (561910)
- SIC
- Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
- akta.pro secondary industries
- Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
Keywords
Where CONFAB is headquartered
LocationHeadquarters
- HQ city
- Saint-hubert
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
CONFAB business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Pharmaceutical Manufacturing: Full-service CDMO providing end-to-end pharmaceutical manufacturing including development, technology transfer, analytical services, and packaging for prescription and OTC medications, generics, controlled drugs, and veterinary products across liquid, solid, and semi-solid dosage forms
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
CONFAB product offering
Product offeringCore offering
CONFAB is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that manufactures and packages non-sterile dosage form products (liquid, solid, and semi-solid) for prescription and OTC medications, generics, controlled drugs, and veterinary products. The offering spans drug development, technology transfer, integrated analytical laboratory services, and packaging with serialization and aggregation capabilities, delivered under a single project manager from a 100,200-square-foot FDA-, Health Canada-, EMEA-, CFIA-, Cofepris-, and PMDA-approved facility in Saint-Hubert, Quebec.
Product overview
CONFAB is a Contract Development and Manufacturing Organization (CDMO) offering comprehensive pharmaceutical manufacturing services. The company operates as a single unified offering encompassing manufacturing of non-sterile dosage forms (liquid, solid, and semi-solid) paired with integrated services including drug development, technology transfer, and pharmaceutical analysis. The product portfolio centers on manufacturing capabilities with complementary services that work together to provide end-to-end support from formulation through commercialization.
Differentiator
Problem solved
Functional benefit
Products and services
- Liquid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in liquid form including solutions, suspensions, nasal sprays, oral products, topical products, syrups, and oils for pharmaceutical companies needing non-sterile liquid dosage manufacturing.
- Solid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in solid form including tablets (core, coated, printed, printed and coated), capsules, single-dose powder pouches, powder in bulk, tablets-in-tablets, and capsules-in-capsules using low-shear, high-shear, wet, dry granulation, and direct compression methods for pharmaceutical companies.
- Semi-Solid Dose Pharmaceutical Manufacturing Contract manufacturing of pharmaceutical products in semi-solid form including rectal suppositories, vaginal ovules, creams, ointments, gels, and pastes for pharmaceutical companies requiring these dosage forms.
- Pharmaceutical Packaging Services Comprehensive packaging services for all dosage forms including bottles, droppers, syringes, jars, single-dose pouches, blister packs, with options for child-resistant caps, security seals, and serialization/aggregation capabilities for pharmaceutical companies.
- Drug Development Services Full-service pharmaceutical development including reverse engineering, complete drug development from concept, improvement of existing formulations, and development of manufacturing processes for liquid, solid, and semi-solid forms, designed for pharmaceutical companies seeking formulation through regulatory submission and commercial launch preparation support.
- Technology Transfer Services Pharmaceutical technology transfer services adapting approved processes to CONFAB's facility, including engineering batches, pilot batches, clinical trial placebos, commercial scale-up batches, DOE studies, and process validation for pharmaceutical companies transferring manufacturing into CONFAB's facility.
- Pharmaceutical Analysis Services Internal analytical laboratory services including raw material testing, packaging component testing, finished product testing, method development, verification, validation, method transfer, and stability chamber testing for pharmaceutical companies requiring turnkey analytical support.
Quantifiable outcome
- Manufacturing approximately 15 different drugs for single clients with full-service capability from development through packaging
- +1 more outcomes
Companies that use CONFAB
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
CONFAB technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CONFAB partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
CONFAB competitors and assessment
Company assessmentDirect peers
- Corealis Pharma: Quebec-based pharmaceutical CDMO offering non-sterile solid, semi-solid, and liquid dose development and manufacturing with integrated analytical services - directly comparable to Confab in geography, dosage forms, and customer segment.
- Halo Pharma: North American CDMO specializing in non-sterile solid, liquid, and semi-solid dosage forms for pharmaceutical companies, including a portfolio of pediatric and controlled products - closely comparable to Confab in scope and customer base.
- Pillar5 Pharma (now part of Astrea BioSeparates): Canadian pharmaceutical CDMO providing non-sterile manufacturing of solid, liquid, and semi-solid dosage forms with analytical and packaging services - directly comparable to Confab in geography, service mix, and small-to-mid-sized pharma customer focus.
- Heraeus Pharma / Hälsa Pharma: Mid-sized pharmaceutical CDMO focused on solid oral dose manufacturing and packaging for pharma companies, comparable to Confab in dosage-form specialty and mid-market positioning but without Confab's controlled-substance and Canada-based capabilities.
Broad incumbents
- Recipharm: Large European pharmaceutical CDMO offering solid, semi-solid, and sterile manufacturing plus development services globally - comparable to Confab in non-sterile dose capabilities but operating at significantly broader scale across multiple continents.
- Aenova Group: European-headquartered CDMO offering solid, semi-solid, and liquid dose contract manufacturing plus packaging for pharmaceutical companies - comparable to Confab in dosage-form and packaging focus, though operating at much larger European-centric scale.
- Delpharm: French pharmaceutical CDMO with pan-European manufacturing network for solid, liquid, semi-solid, and sterile dosage forms serving generics and branded pharma - comparable to Confab in non-sterile services and customer mix, but with broader geographic and sterile reach.
- Catalent: Global pharmaceutical CDMO offering oral, sterile, biologic, and inhaled dose manufacturing plus development services - overlaps Confab in solid/liquid/semi-solid but operates at vastly larger scale with sterile capabilities Confab lacks.
- Thermo Fisher Scientific (Pharma Services / Patheon): Global pharmaceutical services platform combining Patheon CDMO capabilities in API, oral solid, sterile, and biologics manufacturing - overlaps Confab in non-sterile dose services but offers the full integrated stack Confab cannot match.
- Lonza Group: Swiss global CDMO leader in biologics, cell and gene therapies, and small-molecule manufacturing with integrated development services - competes for non-sterile dose work but at massive scale and with capabilities beyond Confab's scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
CONFAB social profiles
Digital presenceCONFAB compliance and trust
Trust signalCompliance6 records
CONFAB financial estimates
Financial estimateRevenue estimate
Valuation estimate
CONFAB leadership team
Management profileNumber of profiles
CONFAB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CONFAB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CONFAB
What does CONFAB do?
CONFAB is a pharmaceutical Contract Development and Manufacturing Organization (CDMO) that manufactures and packages non-sterile dosage form products (liquid, solid, and semi-solid) for prescription and OTC medications, generics, controlled drugs, and veterinary products. The offering spans drug development, technology transfer, integrated analytical laboratory services, and packaging with serialization and aggregation capabilities, delivered under a single project manager from a 100,200-square-foot FDA-, Health Canada-, EMEA-, CFIA-, Cofepris-, and PMDA-approved facility in Saint-Hubert, Quebec.
Is CONFAB a public or private company?
CONFAB is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CONFAB founded?
CONFAB was founded in 1983. It employs 101 to 250 people.
Where is CONFAB based?
CONFAB is headquartered in Saint-hubert, Canada, in the North America region.
How does CONFAB make money?
One revenue line is on record: contract Pharmaceutical Manufacturing.
Who are CONFAB's main competitors?
Direct peers on record are Corealis Pharma, Halo Pharma, Pillar5 Pharma (now part of Astrea BioSeparates) and Heraeus Pharma / Hälsa Pharma. Broad incumbents are Recipharm, Aenova Group, Delpharm, Catalent, Thermo Fisher Scientific (Pharma Services / Patheon) and Lonza Group.
Does CONFAB have an API?
No public API is recorded for CONFAB.
What industry is CONFAB in?
CONFAB's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 325412 and its SIC code is 2834.